The ability to test for Prostate Specific Antigen (PSA) has revolutionized the diagnosis and management of prostate disease. It is highly recognized that PSA testing plays a fundamental role in the early detection and monitoring of prostate disease, which many times will dictate the manner in which patients are treated. FastPack® IP Total PSA makes this test available to you at your fingertips. The FastPack® IP Total PSA immunoassay is a chemiluminescent immunoassay for the in-vitro quantitative determination of PSA in human serum and plasma as an aid in the management of patients with prostate cancer. The FastPack® IP Total PSA immunoassay is designed for use with the FastPack® IP System.